{"schema_version":"1","generated_at":"2026-11-06T06:06:01.660Z","data_as_of":null,"url":"https://www.findmykol.com/kol/andrew-kin","json_url":"https://www.findmykol.com/kol/andrew-kin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"andrew-kin","name":"Andrew Kin","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Wayne State University","institution_url":"https://www.findmykol.com/institution/wayne-state-university","city":"Detroit","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1407112162","orcid":"0000-0002-3263-2374","openalex":"A5058051518"},"summary":"Andrew Kin is a Hematology physician affiliated with Wayne State University. OpenAlex indexes 71 publications with 256 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":71,"cited_by_count":256,"h_index":8,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":19,"shown":3,"withheld":16,"rows":[{"payer":"PFIZER INC.","program_year":2025,"amount_usd":181.47,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407112162"},{"payer":"Celgene Corporation","program_year":2025,"amount_usd":45.89,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407112162"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":43.25,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407112162"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1407112162","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":57.8,"classes_total":1,"classes":[{"class":"Thalidomide Analog","setting":"prescribed","share_pct":57.8,"drugs":[{"name":"Revlimid","share_pct":100}],"max_beneficiaries":22}]},{"area":"Dermatology","share_pct":19.3,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":19.3,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":11}]},{"area":"Respiratory","share_pct":12.8,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":12.8,"drugs":[{"name":"Hydrocodone-Acetaminophen","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"OA-43 Multi-Center Phase II Trial of Iberdomide and SQ Daratamumab as Post-ASCT Maintenance Therapy in Pts with Multiple Myeloma (the IBEX Trial): Initial Safety Analysis and Interim Efficacy Results.","year":2026,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(26)03344-6","status":"verified"},{"title":"Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010–2020","year":2026,"journal":"Bone Marrow Transplantation","source_url":"https://doi.org/10.1038/s41409-026-02943-9","status":"verified"},{"title":"Outcomes in Stem Cell Transplant Recipients with Myelofibrosis: A Single Center Experience","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.983","status":"verified"},{"title":"Patterns and Predictors of Infection Following CAR T-cell Therapy: A Real-World Single-Center Experience","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.272","status":"verified"},{"title":"Final analysis of daratumumab, carfilzomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.7517","status":"verified"}],"source":"works"},"contact":{"address_1":"4100 JOHN R ST","city":"Detroit","state":"MI","zip":"482012013","phone":"800-527-6266","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1407112162","source":"identity"},"similar":[{"name":"Sonia Hassan","slug":"sonia-hassan","institution":"Wayne State University","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/sonia-hassan","json_url":"https://www.findmykol.com/kol/sonia-hassan/profile.json"},{"name":"Yoram Sorokin","slug":"yoram-sorokin","institution":"Wayne State University","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/yoram-sorokin","json_url":"https://www.findmykol.com/kol/yoram-sorokin/profile.json"},{"name":"Robert Sokol","slug":"robert-sokol","institution":"Wayne State University","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/robert-sokol","json_url":"https://www.findmykol.com/kol/robert-sokol/profile.json"},{"name":"Pranatharthi Chandrasekar","slug":"pranatharthi-chandrasekar","institution":"Wayne State University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/pranatharthi-chandrasekar","json_url":"https://www.findmykol.com/kol/pranatharthi-chandrasekar/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":16,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-04-09","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}